Related Experiment Video
Updated: Mar 2, 2026
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
Differentiating 131I Radiation Sialadenitis From Autoimmune (Sjögren Syndrome) Sialadenitis: Case Report
Louis Mandel1, Loren Wissner Greene2
1Director, Salivary Gland Center; Associate Dean and Clinical Professor, Oral and Maxillofacial Surgery, Columbia University College of Dental Medicine, New York-Presbyterian Medical Center (Columbia Campus), New York, NY.
Abstract:
Radioactive iodine (131I) is used effectively for the treatment of differentiated thyroid cancers. Because it is actively secreted by the salivary glands, radiation damage to these glands can occur. Obstructive swellings after mealtime salivary stimulation are common occurrences. Dry mouth is not usually seen if low doses of 131I are used. A subjective complaint of xerostomia in a patient treated with 131I 75.8 mCi proved to be related to the simultaneous presence of Sjögren syndrome (SS). Serologic, histologic, scintigraphic, and salivary volume findings and the patient's subjective complaints served to establish the pre-existence of SS.
